selective serotonin reuptake inhibitors
GPTKB entity
Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:depression
|
| gptkbp:brand |
gptkb:Celexa
gptkb:Lexapro gptkb:Zoloft gptkb:Prozac gptkb:Paxil |
| gptkbp:contraindication |
liver disease
pregnancy MAO inhibitors |
| gptkbp:dosage_form |
gptkb:liquid
tablets |
| gptkbp:duration |
weeks to months
|
| gptkbp:example |
gptkb:citalopram
gptkb:escitalopram gptkb:paroxetine fluoxetine sertraline |
| gptkbp:healthcare |
1990s
|
| https://www.w3.org/2000/01/rdf-schema#label |
selective serotonin reuptake inhibitors
|
| gptkbp:interacts_with |
NSAIDs
anticoagulants other antidepressants |
| gptkbp:is_monitored_by |
suicidal thoughts
serotonin syndrome |
| gptkbp:mechanism_of_action |
inhibit serotonin reuptake
|
| gptkbp:patient_education |
avoid alcohol
follow dosage instructions do not stop abruptly consult healthcare provider for changes report side effects |
| gptkbp:research_focus |
genetic factors
long-term effects comparative effectiveness treatment-resistant depression |
| gptkbp:route_of_administration |
oral
|
| gptkbp:side_effect |
nausea
insomnia dry mouth weight gain sexual dysfunction |
| gptkbp:symptoms |
dizziness
irritability flu-like symptoms |
| gptkbp:used_for |
gptkb:depression
gptkb:post-traumatic_stress_disorder anxiety disorders obsessive-compulsive disorder panic disorder |
| gptkbp:bfsParent |
gptkb:Seroxat
gptkb:Paroxetine |
| gptkbp:bfsLayer |
6
|